◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › A › ABT

Abbott Laboratories (ABT) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Equipment · DATA UPDATED 2026-08-15

Abbott Laboratories (ABT) operates in the Health Care Equipment industry and is headquartered in Abbott Park, United States with about 122,000 employees. Its market capitalization is roughly $178 billion. In the fiscal year ended 2025-12-31, ABT reported $44.3B in revenue and $6.5B in net income.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

Interactive charts & full statements → Open the ABT valuation workbench →

ABT Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$46.6B	$44.3B	$42.0B	$40.1B	$43.7B	$43.1B	$34.6B	$31.9B	$30.6B	$27.4B	$20.9B	$20.4B	$20.2B	$21.8B	$39.9B	$38.9B	$35.2B	$30.8B	$29.5B	$25.9B	$22.5B
Gross Profit	$26.5B	$24.6B	$21.3B	$20.0B	$22.3B	$23.2B	$17.4B	$16.7B	$15.8B	$13.1B	$11.2B	$11.0B	$10.5B	$9.9B	$10.9B	$23.4B	$20.6B	$17.6B	$17.0B	$14.6B	$12.8B
Gross Margin %	56.8%	55.5%	50.8%	50.0%	51.1%	53.9%	50.2%	52.3%	51.7%	47.7%	53.9%	53.7%	51.8%	45.1%	27.2%	60.3%	58.6%	57.3%	57.7%	56.3%	57.1%
Operating Income (EBIT)	$7.9B	$8.0B	$6.8B	$6.4B	$8.4B	$9.2B	$5.3B	$4.6B	$3.8B	$2.0B	$3.2B	$2.9B	$2.9B	$2.1B	$2.0B	$6.8B	$7.1B	$6.6B	$6.1B	$4.9B	$4.3B
Operating Margin %	17.0%	18.2%	16.3%	16.0%	19.2%	21.4%	15.3%	14.4%	12.6%	7.2%	15.6%	14.4%	14.4%	9.8%	5.0%	17.6%	20.1%	21.4%	20.6%	19.1%	19.3%
Net Income	$5.4B	$6.5B	$13.4B	$5.7B	$6.9B	$7.1B	$4.5B	$3.7B	$2.4B	$477M	$1.4B	$4.4B	$2.3B	$2.6B	$6.0B	$4.7B	$4.6B	$5.7B	$4.9B	$3.6B	$1.7B
Net Margin %	11.7%	14.7%	31.9%	14.3%	15.9%	16.4%	13.0%	11.6%	7.7%	1.7%	6.7%	21.7%	11.3%	11.8%	14.9%	12.2%	13.2%	18.7%	16.5%	13.9%	7.6%
EBITDA	$9.9B	$11.6B	$10.8B	$10.6B	$11.9B	$12.2B	$9.0B	$7.9B	$6.9B	$6.1B	$3.1B	$4.8B	$4.2B	$3.6B	$3.5B	$9.3B	$9.1B	$9.5B	$8.2B	$6.9B	$4.3B
Earnings Per Share (EPS)	$3.11	$3.73	$7.67	$3.27	$3.93	$3.95	$2.52	$2.07	$1.34	$0.27	$0.94	$2.94	$1.50	$1.64	$3.75	$3.01	$2.97	$3.70	$3.13	$2.31	$1.12
Shares Outstanding (M)	1,743M	1,747M	1,748M	1,749M	1,764M	1,789M	1,786M	1,781M	1,770M	1,749M	1,483M	1,506M	1,527M	1,574M	1,592M	1,570M	1,556M	1,555M	1,561M	1,560M	1,537M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ABT Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$12.6B	$11.2B	$11.5B	$11.4B	$11.1B	$10.4B	$11.0B	$10.6B
Gross Profit	$7.3B	$6.3B	$6.5B	$6.3B	$6.3B	$5.4B	$5.6B	$5.4B
Gross Margin %	58.0%	56.3%	57.0%	55.8%	56.4%	52.6%	51.0%	51.0%
Operating Income (EBIT)	$1.8B	$1.8B	$2.3B	$2.1B	$2.1B	$1.7B	$2.0B	$1.8B
Operating Margin %	14.1%	16.5%	19.6%	18.1%	18.4%	16.3%	18.1%	17.1%
Net Income	$928M	$1.1B	$1.8B	$1.6B	$1.8B	$1.3B	$9.2B	$1.6B
Net Margin %	7.4%	9.7%	15.5%	14.5%	16.0%	12.8%	84.1%	15.5%
EBITDA	$1.8B	$2.2B	$2.8B	$3.1B	$3.0B	$2.7B	$3.0B	$2.9B
Earnings Per Share (EPS)	$0.53	$0.62	$1.02	$0.94	$1.02	$0.76	$5.29	$0.94
Shares Outstanding (M)	1,743M	1,747M	1,747M	1,749M	1,751M	1,747M	1,746M	1,748M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ABT Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$9.9B	$9.6B	$8.6B	$7.3B	$9.6B	$10.5B	$7.9B	$6.1B	$6.3B	$5.6B	$3.2B	$3.0B	$3.7B	$3.3B	$9.3B	$9.0B	$8.7B	$7.3B	$7.3B	$5.2B	$5.3B
Capital Expenditures (CapEx)	$2.0B	$2.2B	$2.2B	$2.2B	$1.8B	$1.9B	$2.2B	$1.6B	$1.4B	$1.1B	$1.1B	$1.1B	$1.1B	$1.1B	$1.8B	$1.5B	$1.0B	$1.1B	$1.3B	$1.7B	$1.3B
Free Cash Flow (FCF)	$7.9B	$7.4B	$6.4B	$5.1B	$7.8B	$8.6B	$5.7B	$4.5B	$4.9B	$4.4B	$2.1B	$1.9B	$2.6B	$2.2B	$7.5B	$7.5B	$7.7B	$6.2B	$6.1B	$3.5B	$4.0B
FCF Margin %	17.0%	16.7%	15.1%	12.6%	17.9%	20.1%	16.5%	14.1%	16.0%	16.2%	10.0%	9.1%	12.8%	10.0%	18.9%	19.2%	21.9%	20.1%	20.5%	13.6%	17.8%
Dividends Paid	$4.3B	$4.1B	$3.8B	$3.6B	$3.3B	$3.2B	$2.6B	$2.3B	$2.0B	$1.8B	$1.5B	$1.4B	$1.3B	$882M	$3.2B	$2.9B	$2.7B	$2.4B	$2.2B	$2.0B	$1.8B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ABT Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$2.5B	$1.3B	$3.3B	$2.8B	$2.0B	$1.4B	$2.9B	$2.7B
Capital Expenditures (CapEx)	$399M	$399M	$689M	$496M	$502M	$484M	$720M	$556M
Free Cash Flow (FCF)	$2.1B	$916M	$2.6B	$2.3B	$1.5B	$933M	$2.1B	$2.1B
FCF Margin %	16.6%	8.2%	22.9%	20.2%	13.9%	9.0%	19.6%	20.2%
Dividends Paid	$1.1B	$1.1B	$1.0B	$1.0B	$1.0B	$1.0B	$958M	$960M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ABT Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$109.2B	$86.7B	$81.4B	$73.2B	$74.4B	$75.2B	$72.5B	$67.9B	$67.2B	$76.2B	$55.0B	$44.0B	$43.8B	$43.0B	$67.2B	$60.3B	$60.6B	$52.6B	$42.4B	$39.7B	$36.2B
Cash & Cash Equivalents	$5.1B	$8.5B	$7.6B	$6.9B	$9.9B	$9.8B	$6.8B	$3.9B	$3.8B	$9.4B	$18.6B	$5.0B	$4.1B	$3.5B	$10.8B	$6.8B	$7.3B	$8.8B	$4.1B	$2.5B	$521M
Total Liabilities	$57.5B	$33.9B	$33.5B	$34.4B	$37.5B	$39.2B	$39.5B	$36.6B	$36.5B	$45.2B	$31.9B	$19.9B	$19.6B	$17.7B	$40.4B	$35.8B	$37.0B	$29.5B	$24.9B	$21.9B	$22.1B
Total Debt (Short + Long-Term)	$3.0B	$13.2B	$14.4B	$14.9B	$17.0B	$18.3B	$19.0B	$18.3B	$19.6B	$27.9B	$22.0B	$9.0B	$7.8B	$6.6B	$20.5B	$15.4B	$18.9B	$16.5B	$11.4B	$12.2B	$12.4B
Total Shareholders' Equity	$51.1B	$52.1B	$47.7B	$38.6B	$36.7B	$35.8B	$32.8B	$31.1B	$30.5B	$30.9B	$20.5B	$21.2B	$21.5B	$25.2B	$26.7B	$24.4B	$22.7B	$23.1B	$17.5B	$17.8B	$14.1B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ABT viewer.

ABT Metric Deep Dives

Other Companies in Health Care Equipment

ISRG · Intuitive Surgical — $141 billion
MDT · Medtronic — $118 billion
SYK · Stryker Corporation — $106 billion
BSX · Boston Scientific — $63 billion
EW · Edwards Lifesciences — $51 billion
BDX · Becton Dickinson — $49 billion
IDXX · Idexx Laboratories — $40 billion
DXCM · Dexcom — $34 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← ABSLAMC All “A” companies ABTC →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.